Skip to Main Content

Advertisement

Skip Nav Destination

FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors

Clin Cancer Res (2023) 29 (18): 3573–3578.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Timothy J.D. Ohlsen
  • Melissa R. Martos
  • Douglas S. Hawkins
Current Opinion in Pediatrics (2024) 36 (1): 57.
  • Gabriella Gálffy
  • Éva Morócz
  • Réka Korompay
  • Réka Hécz
  • Réka Bujdosó
  • Rita Puskás
  • Tímea Lovas
  • Eszter Gáspár
  • Kamel Yahya
  • Péter Király
  • Zoltán Lohinai
Pathology and Oncology Research (2024) 30
  • E.B. Faber
  • Y. Baca
  • J. Xiu
  • P. Walker
  • G. Manji
  • S. Gholami
  • A. Saeed
  • A. Prakash
  • G.P. Botta
  • D. Sohal
  • H.J. Lenz
  • A.F. Shields
  • C. Nabhan
  • W. El-Deiry
  • A. Seeber
  • V. Chiu
  • J. Hwang
  • E. Lou
ESMO Gastrointestinal Oncology (2024) 4: 100042.
  • Alberto Hernando-Calvo
  • Alice Rossi
  • Maria Vieito
  • Emile Voest
  • Elena Garralda
Cancer Treatment Reviews (2024) 128: 102747.
  • Mehrshad Ebrahimpour
  • Hamidreza Hosseinzadeh
  • Farshad Abedi
  • Mohammad Moeini Nodeh
  • Abolghasem Allahyari
  • Amirhossein Sahebkar
  • Omid Arasteh
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
  • Pallabi Halder
  • Anubhav Rai
  • Vishal Talukdar
  • Parthasarathi Das
  • Naga Rajiv Lakkaniga
RSC Medicinal Chemistry (2024) 15 (5): 1452.
Close Modal

or Create an Account

Close Modal
Close Modal